Variant report
Variant | nsv967507 |
---|---|
Chromosome Location | chr7:112234655-112243192 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:112234356..112236045-chr7:112509200..112510734,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs180724538 | chr7:112234686-112234687 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs559986715 | chr7:112234700-112234701 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369197790 | chr7:112234873-112234874 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs375833180 | chr7:112234934-112234935 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs72420969 | chr7:112234937-112234938 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572047967 | chr7:112234948-112234949 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545466022 | chr7:112234950-112234951 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564434141 | chr7:112234952-112234953 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs377011414 | chr7:112234954-112234955 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs71727428 | chr7:112234955-112234956 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7787473 | chr7:112234982-112234983 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141434642 | chr7:112234997-112234998 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs367982357 | chr7:112234998-112234999 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7456426 | chr7:112235003-112235004 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs7456427 | chr7:112235009-112235010 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149217821 | chr7:112235016-112235017 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1476478 | chr7:112235017-112235018 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549581661 | chr7:112235019-112235020 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs12539463 | chr7:112235027-112235028 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2188547 | chr7:112235033-112235034 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs570900992 | chr7:112235075-112235076 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375586469 | chr7:112235093-112235094 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547919370 | chr7:112235102-112235103 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566034609 | chr7:112235106-112235107 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs17159805 | chr7:112235141-112235142 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs185602597 | chr7:112235150-112235151 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs113389925 | chr7:112235157-112235158 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570376875 | chr7:112235180-112235181 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2188548 | chr7:112235267-112235268 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs191332265 | chr7:112235280-112235281 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570027581 | chr7:112235298-112235299 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567904579 | chr7:112235305-112235306 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs10263915 | chr7:112235309-112235310 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs556516594 | chr7:112235317-112235318 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs535518473 | chr7:112235329-112235330 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576296705 | chr7:112235332-112235333 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs553866347 | chr7:112235351-112235352 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs572024341 | chr7:112235355-112235356 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs545806304 | chr7:112235385-112235386 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557297675 | chr7:112235399-112235400 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs145947345 | chr7:112235461-112235462 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543268974 | chr7:112235487-112235488 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561648087 | chr7:112235522-112235523 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs555348124 | chr7:112235568-112235569 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529096523 | chr7:112235581-112235582 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs115277370 | chr7:112235599-112235600 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs183625411 | chr7:112235608-112235609 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs535770508 | chr7:112235683-112235684 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs146418256 | chr7:112235687-112235688 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs140171954 | chr7:112235749-112235750 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 16397240 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Autism | 19401682 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:112230800-112235200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr7:112233200-112235800 | Active TSS | HSMMtube | muscle |
3 | chr7:112234400-112234800 | Enhancers | Brain Germinal Matrix | brain |
4 | chr7:112234400-112235200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr7:112234600-112234800 | Enhancers | Colon Smooth Muscle | Colon |
6 | chr7:112234600-112235800 | Enhancers | Fetal Stomach | stomach |
7 | chr7:112234800-112235400 | Weak transcription | Colon Smooth Muscle | Colon |
8 | chr7:112235000-112236200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr7:112235400-112235600 | Enhancers | Duodenum Smooth Muscle | Duodenum |
10 | chr7:112235400-112235800 | Enhancers | Rectal Smooth Muscle | rectum |
11 | chr7:112235400-112237400 | Enhancers | Colon Smooth Muscle | Colon |
12 | chr7:112235600-112236200 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
13 | chr7:112235800-112236200 | Weak transcription | Rectal Smooth Muscle | rectum |
14 | chr7:112235800-112236800 | Weak transcription | Fetal Stomach | stomach |
15 | chr7:112235800-112237000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr7:112236000-112237000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
17 | chr7:112236000-112237000 | Enhancers | Muscle Satellite Cultured Cells | -- |
18 | chr7:112236200-112236600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
19 | chr7:112236200-112236800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
20 | chr7:112236200-112237400 | Enhancers | Duodenum Smooth Muscle | Duodenum |
21 | chr7:112236200-112237400 | Enhancers | Rectal Smooth Muscle | rectum |
22 | chr7:112236400-112236600 | Enhancers | HSMMtube | muscle |
23 | chr7:112237000-112237200 | Enhancers | Fetal Stomach | stomach |